GSK logo

GSK
Glaxosmithkline plc - ADR

9,492
Mkt Cap
$102.85B
Volume
2.1M
52W High
$61.70
52W Low
$35.45
PE Ratio
13.29
GSK Fundamentals
Price
$51.53
Prev Close
$50.78
Open
$50.84
50D MA
$53.80
Beta
0.30
Avg. Volume
4.33M
EPS (Annual)
$3.72
P/B
4.40
Rev/Employee
$644,088.53
$119,635.62
Loading...
Loading...
News
all
press releases
GSK Stock Declines 9% in a Month: Time to Buy, Hold or Exit?
GSK shares slide after Q1 despite earnings and sales beats, as investors weigh slowing legacy drug sales against strong Specialty Medicines growth.
News Placeholder
More News
News Placeholder
Ralph Baric And UNC's Biodefense Contract Racket Exposed
Ralph Baric And UNC's Biodefense Contract Racket Exposed Authored by Paul D. Thacker via The DisInformation Chronicle, DLA Piper wants to get you, I was told, from a source in DC over the weekend...
News Placeholder
GSK Targets China's Hepatitis B Market Through New Deal
GSK partnered with Sino Biopharmaceutical to advance hepatitis B drug bepirovirsen in China while launching its final buyback tranche.read more...
News Placeholder
GSK Launches Final GBP 0.18 Bln Tranche Of GBP 2 Bln Share Buyback
(RTTNews) - GSK plc (GSK, GSK.L, GS71.DE), on Monday announced the commencement of the fifth and final tranche of its 2 billion pounds share buyback program, covering up to about 0.18 billion pounds...
News Placeholder
GILD Beats Q1 Earnings and Sales Estimates, Lowers '26 EPS View
GILD beats Q1 estimates as HIV and Trodelvy sales rise, but shares slip after the company cuts its 2026 EPS outlook.
News Placeholder
GSK (LON:GSK) Receives Hold Rating from Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a GBX 1,900 price target on shares of GSK in a research note on Wednesday...
News Placeholder
GSK (LON:GSK) Given New GBX 2,100 Price Target at Citigroup
Citigroup reduced their price objective on GSK from GBX 2,250 to GBX 2,100 and set a 'neutral' rating for the company in a report on Wednesday...
News Placeholder
Tempus AI's Big Pharma AI Partnerships Are Getting Bigger And Stickier
Tempus AI (TEM) Q1 results: Revenue up 36.1% to $348.1M, beating estimates. TEM raises 2026 outlook amid strong AI & diagnostic demand.read more...
News Placeholder
129,513 Shares in GSK PLC Sponsored ADR $GSK Acquired by PFA Pension Forsikringsaktieselskab
PFA Pension Forsikringsaktieselskab purchased a new position in shares of GSK PLC Sponsored ADR (NYSE:GSK - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 129,513 shares of the pharmaceutical company's...
News Placeholder
SMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab Setback
Summit Therapeutics posts narrower Q1 loss but stock plunges 25% after ivonescimab setback, raising concerns over its late-stage cancer pipeline progress.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available